Representation of Shanghai Jiuchuan Investment Group, an investment company which owns more than 3,000 hospitals in China, in the acquisition of SHL Telemedicine Ltd, a company that develops and markets personal telemedicine systems and provides medical call center services.
Representation of Lumenis, a global leader in the field of minimally-invasive clinical solutions for the surgical, ophthalmology and aesthetic markets, in its acquisition by XIO Group, a Chinese private equity fund, for approximately $510 million.
Representation of Domain Elite, a U.S. venture capital firm investing in breakthrough life sciences technologies, in an equity investment in SMART Medical Systems, an Israeli developer and manufacturer of innovative endoscopy and colonoscopy products, and its HK subsidiary Medico. This transaction was chosen as one of the “Deals of the year 2014” by “China Business Law Journal”.
Representation of Baidu, a Chinese web services company, in various equity investments in Israeli start-up companies.
Representation of Shenyang Yuanda, a large-scale international manufacturer and installer of primary construction-related products, in the acquisition of a controlling interest in an Israeli high-tech company.
Representation of Ironsource Ltd., a data and analytics company, in receiving an equity investment from major Chinese financial institutions.
Representation of Tianan Insurance Group and JT Capital Group, a consortium of PRC and HK investors, in their bid for acquiring control in Clal Insurance Group, one of the largest insurance companies in Israel.
Representation of China Everbright, a financial services company, in an equity investment in Real Imaging, an Israeli medical device company.
Representation of Shenjiang 360, one of China’s largest management consulting and private equity investment advisory firms, in various investments in Israeli high-tech companies.
Representation of eToro, a social investment network, in receiving an equity investment from Ping An, a Chinese insurance company.
Representation of a major Chinese SOE in an investment in one of the leading Israeli Venture Capital Funds.
Representation of various Chinese investors in the establishment of Venture Capital Funds with Israeli Co-GPs.
